Sunyoung S. Lee

791 total citations
43 papers, 265 citations indexed

About

Sunyoung S. Lee is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Sunyoung S. Lee has authored 43 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Hepatology and 18 papers in Surgery. Recurrent topics in Sunyoung S. Lee's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Sunyoung S. Lee is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Sunyoung S. Lee collaborates with scholars based in United States, South Korea and United Kingdom. Sunyoung S. Lee's co-authors include Ahmed O. Kaseb, Tarık Demir, Eugene J. Koay, Yehia I. Mohamed, Betül Gök Yavuz, Michael A. Curran, Vittorio Cristini, Milind Javle, Elshad Hasanov and James C. Yao and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sunyoung S. Lee

36 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunyoung S. Lee United States 10 112 99 79 58 48 43 265
Jiashuo Chao China 9 67 0.6× 116 1.2× 74 0.9× 45 0.8× 41 0.9× 20 255
Maria Aurelia Barbera Italy 9 104 0.9× 134 1.4× 69 0.9× 70 1.2× 53 1.1× 19 284
Cheng‐Qian Zhong China 9 139 1.2× 47 0.5× 95 1.2× 36 0.6× 77 1.6× 20 277
Linfeng Xu China 10 128 1.1× 40 0.4× 73 0.9× 57 1.0× 64 1.3× 24 251
Ningyuan Wen China 7 110 1.0× 62 0.6× 71 0.9× 63 1.1× 66 1.4× 22 241
Vito Sansone Italy 9 122 1.1× 68 0.7× 41 0.5× 51 0.9× 44 0.9× 22 261
Chenhe Yi China 8 111 1.0× 157 1.6× 119 1.5× 63 1.1× 81 1.7× 16 354
P. Merle United States 3 195 1.7× 60 0.6× 95 1.2× 44 0.8× 79 1.6× 5 333
Weiping Yuan China 10 126 1.1× 53 0.5× 79 1.0× 19 0.3× 27 0.6× 32 271
Aibing Xu China 7 82 0.7× 74 0.7× 47 0.6× 37 0.6× 39 0.8× 10 179

Countries citing papers authored by Sunyoung S. Lee

Since Specialization
Citations

This map shows the geographic impact of Sunyoung S. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunyoung S. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunyoung S. Lee more than expected).

Fields of papers citing papers by Sunyoung S. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunyoung S. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunyoung S. Lee. The network helps show where Sunyoung S. Lee may publish in the future.

Co-authorship network of co-authors of Sunyoung S. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Sunyoung S. Lee. A scholar is included among the top collaborators of Sunyoung S. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunyoung S. Lee. Sunyoung S. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adesoye, Taiwo, Ecaterina E. Dumbrava, Kanwal Raghav, et al.. (2025). Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach. Clinical Cancer Research. 32(2). 260–290.
2.
3.
4.
Yim, Sun Young, Sung Hwan Lee, Yun Seong Jeong, et al.. (2024). Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial. Clinical and Molecular Hepatology. 30(4). 807–823. 8 indexed citations
5.
Yavuz, Betül Gök, Yehia I. Mohamed, Sunyoung S. Lee, et al.. (2024). Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 7(4). 255–262. 3 indexed citations
6.
Newhook, Timothy E., Ching‐Wei D. Tzeng, Hop S. Tran Cao, et al.. (2024). Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?. Annals of Surgical Oncology. 31(5). 3062–3068. 2 indexed citations
7.
Bhamidipati, Deepak, Funda Meric‐Bernstam, Shubham Pant, et al.. (2024). Characterizing outcomes of ERBB2-amplified biliary tract cancer.. Journal of Clinical Oncology. 42(3_suppl). 492–492.
8.
Lee, Ju‐Seog, Sun Young Yim, Sung Hwan Lee, et al.. (2024). Abstract LB090: Predictive genomic biomarkers for atezolizumab plus bevacizumab combination immunotherapy response in liver cancer: Insights from the IMbrave150 trial. Cancer Research. 84(7_Supplement). LB090–LB090. 1 indexed citations
9.
De, Brian, Sunyoung S. Lee, Joseph Abi Jaoude, et al.. (2023). Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. The Oncologist. 28(4). 327–332. 2 indexed citations
10.
Cao, Hop S. Tran, Russell G. Witt, Khaled M. Elsayes, et al.. (2023). Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. The Oncologist. 29(6). e803–e810.
11.
Lee, Sunyoung S., Fei Duan, Sonali Jindal, et al.. (2023). Translational analysis of combination of 5-fluorouracil (FU), interferon (IFN)-alpha2, and nivolumab in unresectable fibrolamellar liver cancer.. Journal of Clinical Oncology. 41(16_suppl). e16198–e16198.
12.
DiPeri, Timothy P., Ming Zhao, Kurt W. Evans, et al.. (2023). Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma. Journal of Hepatology. 80(2). 322–334. 18 indexed citations
13.
Yılmaz, Bülent, Blessie Elizabeth Nelson, Harrys A. Torres, et al.. (2023). Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience. The Oncologist. 28(8). 714–721. 8 indexed citations
14.
Lin, Yuan‐Mao, Bryan Fellman, Iwan Paolucci, et al.. (2023). Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes. Journal of Gastrointestinal Surgery. 27(9). 1867–1875. 2 indexed citations
15.
De, Brian, Marcus A. Florez, Sunyoung S. Lee, et al.. (2023). Dose-escalated pancreas radiotherapy for unresected pancreatic adenocarcinoma: Patterns of care and survival in the United States.. Journal of Clinical Oncology. 41(4_suppl). 676–676. 1 indexed citations
16.
De, Brian, Hop S. Tran Cao, Jean‐Nicolas Vauthey, et al.. (2022). Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer. 128(13). 2529–2539. 5 indexed citations
17.
Hsiehchen, David, Dong Yang, Muhammad Shaalan Beg, et al.. (2022). Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers. Nature Communications. 13(1). 7477–7477. 9 indexed citations
18.
Yavuz, Betül Gök, Elshad Hasanov, Sunyoung S. Lee, et al.. (2021). Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 8. 1195–1207. 32 indexed citations
19.
Kaseb, Ahmed O., S. Cheenu Kappadath, Sunyoung S. Lee, et al.. (2021). A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 1129–1145. 10 indexed citations
20.
Demir, Tarık, Sunyoung S. Lee, & Ahmed O. Kaseb. (2021). Systemic therapy of liver cancer. Advances in cancer research. 149. 257–294. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiashuo Chao Breakdown of academic impact, for papers by Maria Aurelia Barbera Breakdown of academic impact, for papers by Cheng‐Qian Zhong Breakdown of academic impact, for papers by Linfeng Xu Breakdown of academic impact, for papers by Ningyuan Wen Breakdown of academic impact, for papers by Vito Sansone Breakdown of academic impact, for papers by Chenhe Yi Breakdown of academic impact, for papers by P. Merle Breakdown of academic impact, for papers by Weiping Yuan Breakdown of academic impact, for papers by Aibing Xu
Rankless by CCL
2026